After >10 passages, the majority of the PPT2 cells expressed cell surface markers commonly used for the isolation of tumor-initiating cells from different types of human cancer, including CD133, CD44, CD44v6, EpCAM, CD166, CD49f, and presently, they retain these features after more than 26 passages. This evidence concerns the gene ITGA6 and cancer.